Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Response deadline
- Nov 9, 2026 Due in 69 days
- Date posted
- Aug 31, 2026
- Source
- Open notice
Description
This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite an application from the eligible organization to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, applications will be peer-reviewed, and only meritorious applications will be considered for funding. Through this NOFO, the National institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites an application to continue to follow the Epidemiology of Diabetes Interventions and Complications (EDIC) cohort through a collaborative cooperative agreement that addresses specific knowledge gaps in the development and progression of type 1 diabetes complications. Applications should include hypothesis-based research, support for cohort infrastructure and/or maintenance, continued follow-up, and supporting collaborative research to utilize the EDIC cohort as well as its data set and biologic/genetic samples.
Classifications
- NAICS93.847
Documents (1)
- RFA-DK-27-112-Full-Announcement.htmltext/html;charset=UTF-8133 KBNot yet available
Contacts
- niddk_dem@nih.gov301-402-2541
Similar contracts
- Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)Due Nov 6, 2026
- Cooperative Centers for Experimental Hematology (CCEHs) (U54- Clinical Trial Not Allowed)Due Sep 30, 2026
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)Due Nov 9, 2026
- Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)Due Oct 20, 2026
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)Due Feb 10, 2027
- Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)Due Oct 9, 2026